Björklund Pharma

  • Home
  • Company
  • Science & Innovation
  • Publications
  • Media
  • Contact
    • Contact Form

Science & Innovation

Björklund Pharma is an early-stage biopharmaceutical company with product candidates within the following therapeutic areas:

  • Psychiatry
  • Neurology
  • Pain
  • Sleep
  • Dermatology
  • Ophthalmology
  • Cardiology
  • Gastrointestinal
  • Immunology
  • Infectious Diseases
  • Bone Metabolism
  • Toxicology
  • Pulmonology/Respiratory
  • Renal/Hepatic
  • Women’s Health
  • Nutraceuticals
  • Sports Supplements

Most of the company’s product candidates are in an early preclinical stage. During the preclinical phase, various tests and experiments will be conducted to determine drugs’ safety, effectiveness, and how they are metabolized in the body. This information will be used to design and plan clinical trials to test the drugs on human subjects.

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment

RSS CONEM Autism Research

  • Zinc, Copper, and Autism Spectrum Disorder
  • Digestive Enzyme Therapy: A Possible Option in Autism Spectrum Disorder
  • Vitamin D Deficiency Correlates with Severity of Autism and Shows Improvement with Supplementation
  • ADHD, Autism, and Phenylketonuria
  • Serum Zinc and Copper Levels in Autistic Children

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2023 Björklund Pharma AS